Search Results 8791-8800 of 42341 for oral
The purpose of this 12 week study is to assess the safety of oral IW-1973 when administered to patients with heart failure with preserved ejection fraction ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Merit Award: Summa Cum Laude for Oral Presentation, Co-Author and Mentor to First Author (First author: A. Roldan-Alzate), 20th Scientific Meeting and ...
Your doctor may prescribe tetracycline eye ointment or oral azithromycin (Zithromax). Azithromycin appears to be more effective than tetracycline, but it's ...
Direct-Acting Oral Anticoagulants (DOACS) are permitted. Patient is currently receiving or has received systemic corticosteroids ≤ 2 weeks prior to ...
This study is to investigate the clinical usefulness of Gleolan (aminolevulinic acid hydrochloride, 5-ALA), an oral agent for the detection and visualization of ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Thyroid cancer, Skin lesion, Laryngeal cancer, Salivary gland tumor, Salivary ...
Patients receiving oral anticoagulants, as well as those with an acquired or congenital coagulopathy, are at increased risk for ICH and hemorrhagic ...
* Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...
In addition, oral corticosteroid treatment significantly alters the frequency and function of Breg subsets, which could lead altered clinical outcomes. Aims ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.